For Research Purposes Only

growth-hormonenot-approved

CJC-1295

CJC-1295 (with or without DAC)

Overview

A growth hormone releasing hormone (GHRH) analog that stimulates GH release. Available with DAC (Drug Affinity Complex) for extended half-life or without for shorter action.

Mechanism of Action

Mimics GHRH to stimulate the pituitary gland to produce and release growth hormone. The DAC version binds to albumin for prolonged effect.

Popular Research Uses

  • GH optimization
  • Anti-aging
  • Recovery
  • Muscle building
  • Fat loss

Potential Side Effects

  • Water retention
  • Joint pain
  • Carpal tunnel symptoms
  • Increased hunger
  • Flushing

Warnings

  • FDA flagged for safety risks
  • Requires injection
  • May cause GH-related side effects
  • No approved use
  • Quality varies widely

Dosage Information

Often stacked with Ipamorelin. DAC version provides sustained GH elevation.

Research Sources

Disclaimer: This content is for research and educational purposes only. CJC-1295 is not approved for human consumption. Always consult with qualified healthcare professionals before making any decisions related to peptide research.